Evidence map›Paper›PMID 24981454›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Mammalian target of rapamycin complex 2 modulates αβTCR processing and surface expression during thymocyte development.

Po-Chien Chou, Won Jun Oh, Chang-Chih Wu, Joseph Moloughney, Markus A Rüegg, Michael N Hall, Estela Jacinto, Guy Werlen

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Food for thought: Nutrient metabolism controlling early T cell development.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  2. Review
  3. Article
  4. Metabolic regulation of T cell development.Frontiers in immunology · 2022
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Po-Chien ChouDepartment of Biochemistry and Molecular Biology, Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ 08854;
Won Jun OhDepartment of Biochemistry and Molecular Biology, Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ 08854;
Chang-Chih WuDepartment of Biochemistry and Molecular Biology, Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ 08854;
Joseph MoloughneyDepartment of Biochemistry and Molecular Biology, Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ 08854;
Markus A RüeggBiozentrum, University of Basel, CH 4056 Basel, Switzerland; and.
Michael N HallBiozentrum, University of Basel, CH 4056 Basel, Switzerland; and.
Estela JacintoDepartment of Biochemistry and Molecular Biology, Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ 08854; jacintes@rwjms.rutgers.edu guy.werlen@rutgers.edu.
Guy WerlenDepartment of Cell Biology and Neuroscience, Rutgers, The State University of New Jersey, Piscataway, NJ 08854 jacintes@rwjms.rutgers.edu guy.werlen@rutgers.edu.
Rutgers, The State University of New Jersey · USJohnson University · USUniversity of Basel · CH

Funding

The Regulation of Cell Metabolism and Proliferation by mTOR complex 2R01GM079176 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI JACINTO, ESTELA · 2008 to 2017
$2.8M
Cotranslational Functions of MTORR01CA154674 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI JACINTO, ESTELA · 2012 to 2017
$1.8M
NCI NIH HHS CA154674NCI NIH HHS R01 CA154674NIGMS NIH HHS GM079176NIGMS NIH HHS R01 GM079176
6 · The paper itself

Abstract

An efficient immune response relies on the presence of T cells expressing a functional TCR. Whereas the mechanisms generating TCR diversity for antigenic recognition are well defined, what controls its surface expression is less known. In this study, we found that deletion of the mammalian target of rapamycin complex (mTORC) 2 component rictor at early stages of T cell development led to aberrant maturation and increased proteasomal degradation of nascent TCRs. Although CD127 expression became elevated, the levels of TCRs as well as CD4, CD8, CD69, Notch, and CD147 were significantly attenuated on the surface of rictor-deficient thymocytes. Diminished expression of these receptors led to suboptimal signaling, partial CD4(-)CD8(-) double-negative 4 (CD25(-)CD44(-)) proliferation, and CD4(+)CD8(+) double-positive activation as well as developmental blocks at the CD4(-)CD8(-) double-negative 3 (CD25(+)CD44(-)) and CD8-immature CD8(+) single-positive stages. Because CD147 glycosylation was also defective in SIN1-deficient fibroblasts, our findings suggest that mTORC2 is involved in the co/posttranslational processing of membrane receptors. Thus, mTORC2 impacts development via regulation of the quantity and quality of receptors important for cell differentiation.

Indexed as

AnimalsCarrier ProteinsCell DifferentiationGene DeletionGene Expression Regulation, DevelopmentalHumansJurkat CellsMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2Membrane ProteinsMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMultiprotein ComplexesProtein Processing, Post-TranslationalCarrier ProteinsMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2Membrane ProteinsmTOR protein, mouseMultiprotein ComplexesProtein SubunitsRapamycin-Insensitive Companion of mTOR ProteinReceptors, Antigen, T-Cell, alpha-betarictor protein, mouseTOR Serine-Threonine Kinases

Identifiers

PMID24981454
PMCPMC4108500
OpenAlexW2131987183

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.